Article Details
Retrieved on: 2021-09-02 20:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today ...
Article found on: www.prnewswire.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here